
About Dongbang FTL India Private Limited
Data last updated:
Dongbang FTL India Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Dongbang Future Tech&Life Co., Ltd.. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24306MH2020FTC337604. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹38 Lakh and a paid-up capital of ₹38 Lakh. It is led by director Jongyoon Kim.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 101 Kumkum Building Near Daulat Nagar Police Chowky Daulat Nagar Rd. No. 8, Mumbai, Maharashtra, India – 400066.
The company is associated with 1 brand: Aartia Kem Science.
For more details, the company can be reached via its website aartiakem.com.
Company details
Contact details
Dongbang FTL India Private Limited's registered office is in Mumbai, Maharashtra. Its website is aartiakem.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address101 Kumkum Building Near Daulat Nagar Police Chowky Daulat Nagar Rd. No. 8, Mumbai, Maharashtra, India – 400066
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Dongbang FTL India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Dongbang FTL India operates one associated brand: Aartia Kem Science. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers API development, manufacturing, regulatory support, and quality pharmaceutical products. | aartiakem.com |
Business activity
The main business activity of Dongbang FTL India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Dongbang FTL India Private Limited
FY 2024 filings availableDongbang FTL India Private Limited reported revenue of ₹429 for FY 2022.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹429 | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Dongbang FTL India Private Limited, buy the company report.
Board of directors and KMP of Dongbang FTL India Private Limited
Dongbang FTL India Private Limited currently reports 1 director and 1 key managerial person. 3 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hun Suk Chung | Ceo | 13 Mar 2020 | 6 Years 7 Months | Current |
| Jongyoon Kim | Director | 12 Feb 2020 | 6 Years 9 Months | Current |
Auditor
Dongbang FTL India Private Limited is audited by MANAN AGARWAL & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANAN AGARWAL & ASSOCIATES | FY 2022 | 024558N |
Shareholding
The shareholding of Dongbang FTL India Private Limited is on record for FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Dongbang FTL India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Dongbang FTL India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dongbang FTL India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dongbang FTL India has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Dongbang FTL India Private Limited, buy the company report.
Recent activity
Dongbang FTL India Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Urmee Alpesh Sangani ceased to be Director on 28 Feb 2025.
Frequently asked questions
Dongbang FTL India is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 February 2020 (6+ years old) and is registered under CIN U24306MH2020FTC337604.
Dongbang FTL India has 2 current directors and KMP:
- Jongyoon Kim - Director
- Hun Suk Chung - Ceo
The latest financial statements of Dongbang FTL India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
No. Dongbang FTL India has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Dongbang FTL India is U24306MH2020FTC337604. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dongbang FTL India was incorporated on 12 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Urmee Alpesh Sangani ceased to be Director on 28 Feb 2025. Hun Suk Chung was appointed as CEO on 13 Mar 2020. Hun Suk Chung ceased to be Director on 13 Mar 2020. Dongbang FTL India has 4 board changes on record in total.
Dongbang FTL India can be reached through the website aartiakem.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Dongbang FTL India is at 101 Kumkum Building Near Daulat Nagar Police Chowky Daulat Nagar Rd. No. 8, Mumbai, Maharashtra, India – 400066.
Dongbang FTL India operates in the pharma industry, in the drug formulation and development segment.

